Clinical Trial

CorEvitas Multiple Sclerosis (MS) Registry

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for MS in a cohort of patients cared for by neurologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-09-21; most recent amendment 2026-02-05.
Trial Details
NCT Number NCT03291756
Lead Sponsor CorEvitas
Conditions Multiple Sclerosis
Enrollment 1,000 participants
Start Date 2017-08-10
Primary Completion 2100-12 (estimated)
Study Completion 2100-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-09